Emvision Medical Devices Ltd. · ASX:EMV
Emvision Medical Devices — Bell Potter Healthcare Conference (November 2020)
12 slides from Emvision Medical Devices's conference presentation, Nov 25, 2020
Slide 1: Bell Potter Healthcare Conference
www.emvision.com.au For personal use only BELL POTTER HEALTHCARE CONFERENCE ASX:EMV 70.2M $12.7M $4.00* $280.8M* $268.1M* * Undiluted market cap based on closing price of $4 Friday 20th November 2020
Slide 2: Disclaimer
DISCLAIMER For personal use only This presentation has been prepared by EMVision Medical Devices Limited (“EMVision” or “the Company”). This presentation is not a financial product or investment advice or recommendation, offer or invitation by any person or to any person to sell or purchase securiti
Slide 3: Transformative Point-of-Care Imaging
TRANSFORMATIVE POINT-OF-CARE IMAGING For personal use only FAST SAFE PORTABLE VIDEO ACCESSIBLE Video available on EMVision website (www.emvision.com.au) ADDRESSING ACCESSABILITY LOW-COST HARDWARE PLATFORM MODALITY 2/3rds of the world does Energy emitted from a Applications across the not have access
Slide 4: Bringing Imaging to Where Stroke Occurs Will Save Lives
BRINGING IMAGING TO WHERE STROKE OCCURS WILL SAVE LIVES For personal use only STROKE IS A GLOBAL SOCIETAL THERE ARE EFFECTIVE THEY ARE TIME & HEALTH ECONOMIC BURDEN TREATMENTS AVAILBLE SENSITIVE WHAT CLINCIANS NEED TO KNOW… 1 ST GENERATION DEVICE Detect clinically significant changes, at the bedside
Slide 5: Bringing Imaging Bedside
BRINGING IMAGING BEDSIDE For personal use only TODAY’S CHALLENGES Transport of patients from ICU to radiology can increase the risks of complications, with adverse events occurring in as many as 71% of in-hospital transports. Transporting unwell patients is also associated with complex logistical ch
Slide 6: EMVision's Pilot Clinical Trial
EMVISION’S PILOT CLINICAL TRIAL For personal use only STUDY DESIGN STUDY OBJECTIVE PATIENT COHORT PILOT CLINICAL TRIAL PRIMARY END POINT ACHIEVED 30 STROKE PATIENTS ENROLLED • The single-site study, at the Princess • The primary endpoint was the collection of a • The study enrolled and processed Ale
Slide 7: Fusion with Classifier - Examples
FUSION WITH CLASSIFIER - EXAMPLES Ground Truth Fusion Fusion + Classification Ground Truth Fusion Fusion + Classification For personal use only R L R L R L R L R L R L Haemorrhagic Ischaemic R L R L R L R L R R L L R L R L R L R L R L R L R L R L R L R L R L R L www.emvision.com.au 7 The above examp
Slide 8: Study Outcomes & Upcoming Milestones
STUDY OUTCOMES & UPCOMING MILESTONES For personal use only 93.3% - 96%* 86.7% - 96%* ACCURACY ACCURACY STROKE SUBTYPE LOCALISATION IN OPERATOR AND CLASSIFICATION CORRECT QUADRANT PATIENT FEEDBACK Collect data from stroke patients, Compare EMVision scans with Despite being a prototype, positive both
Slide 9: More Lives Could Be Saved with a Lightweight Scalable Imaging Solution
MORE LIVES COULD BE SAVED WITH A LIGHTWEIGHT SCALABLE IMAGING SOLUTION For personal use only Nearly 10x more patients treated within the “golden hour” (first 60 minutes) Mobile Stroke Unit (MSU) with Melbourne Mobile Stroke Unit A Mobile Stroke Unit (MSU) is a custom-built specialist Ambulance vehic
Slide 10: Flexible & Attractive Revenue Models
FLEXIBLE & ATTRACTIVE REVENUE MODELS Direct or Distributor For personal use only MONTHLY SUBSCRIPTION MODEL CAPITAL EQUIPMENT & CONSUMABLES MODEL Delivery of the unit Training Consumables Device Sales Software updates New algorithm sequences as they come out Potential integration into PACS and EMR A
Slide 11: Team
TEAM Significant experience developing and commercialising medical devices For personal use only Dr Ron Weinberger John Keep Scott Kirkland Prof Stuart Crozier Robert Tiller Forough Khandan CEO & MD Non-Executive Chairman Executive Director Co-inventor Head of Design Head of Program Management Forme
Slide 12: Get in Touch
For personal use only www.emvision.com.au GET IN TOUCH Dr Ron Weinberger Scott Kirkland CEO and MD, EMVision Executive Director and Co-Founder, EMVision E: rweinberger@emvision.com.au E: skirkland@emvision.com.au P: 02 8667 5337 P: 02 8667 5337
EMVision Medical Devices — Bell Potter Healthcare Conference (November 2020) on 6ix